These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 338625)

  • 41. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
    Dijkmans BA; Mattie H; Hermans J; van Furth R
    J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variations in the anaerobic faecal flora of ten healthy human volunteers with special reference to the Bacteroides fragilis-group and Clostridium difficile.
    Meijer-Severs GJ; van Santen E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):43-52. PubMed ID: 3705797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of iron on mixed infection of Bacteroides fragilis and Escherichia coli in mice.
    Ward CG; Mitchell M; Streitfeld MM
    J Surg Res; 1983 Oct; 35(4):351-3. PubMed ID: 6353067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. III. Possible synergistic effect between anaerobic and aerobic bacteria. An experimental study in rabbits.
    Lykkegaard Nielsen M; Asnaes S; Justesen T
    Scand J Gastroenterol; 1976; 11(3):263-72. PubMed ID: 775613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of a fluorescent antibody technique for the rapid enumeration of Bacteroides fragilis group of organisms in water.
    Fiksdal L; Berg JD
    J Appl Bacteriol; 1987 Apr; 62(4):377-83. PubMed ID: 3298189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival of anaerobic and aerobic bacteria on cotton swabs in three transport systems.
    Yrios JW; Balish E; Helstad A; Field C; Inhorn S
    J Clin Microbiol; 1975 Feb; 1(2):196-200. PubMed ID: 240870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Growth of Bacteroides fragilis in rabbit tracheal organ culture: anaerobiosis and tissue respiration.
    Murakami T; Matsuyama T; Shiraishi S; Hagihara B
    Infect Immun; 1981 Dec; 34(3):1062-4. PubMed ID: 7333664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superoxide dismutase in Bacteroides fragilis and related Bacteroides species.
    Carlsson J; Wrethén J; Beckman G
    J Clin Microbiol; 1977 Sep; 6(3):280-4. PubMed ID: 332713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
    Nagy E; Justesen US; Eitel Z; Urbán E;
    Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amniotic fluid activity against Bacteroides fragilis and group B streptococci.
    Evaldson G; Nord CE
    Med Microbiol Immunol; 1981; 170(1):11-7. PubMed ID: 7029235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxygen-independent killing of Bacteroides fragilis by granule extracts from human polymorphonuclear leukocytes.
    Wetherall BL; Pruul H; McDonald PJ
    Infect Immun; 1984 Mar; 43(3):1080-4. PubMed ID: 6698601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of laparoscopic models on anaerobic bacterial growth with bacteroides fragilis in experimentally induced peritonitis.
    Sare M; Demirkiran AE; Tastekin N; Durmaz B
    J Laparoendosc Adv Surg Tech A; 2003 Jun; 13(3):175-9. PubMed ID: 12855099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formation of glycosidases in batch and continuous culture of Bacteroides fragilis.
    Berg JO; Nord CE; Wadström T
    Appl Environ Microbiol; 1978 Feb; 35(2):269-73. PubMed ID: 25044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli.
    Namavar F; Verweij-Van Vught AM; Bal M; MacLaren DM
    J Med Microbiol; 1987 Sep; 24(2):119-24. PubMed ID: 3309320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New medium for selection and presumptive identification of the Bacteroides fragilis group.
    Livingston SJ; Kominos SD; Yee RB
    J Clin Microbiol; 1978 May; 7(5):448-53. PubMed ID: 659574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.